chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Sepsis, Urinary tract infection, Urine analysis abnormal, White blood cell count normal
Clinical narrative: COVID+ 10/14/22 - Vaccination status  - Moderna x4 + bivalent booster BRIEF OVERVIEW: Admission Date: 10/14/2022 Discharge Date: Oct 16, 2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Pyelonephritis Sepsis Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present COVID-19   HOSPITAL COURSE: The patient is a 76 y.o. female who presented today to the ER secondary to flank pain and fever.  Few days ago, she started to complain of dysuria, chills and flank pain.  Yesterday, she called her PCP, had urine sample checked which was positive. She was was started on Bactrim.  Last night, she started to complain of worsening bilateral flank pains together with generalized weakness and developed fever.  She reported having nausea but denied any vomiting, cough/congestion shortness of breath or chest pain.  She did receive COVID 19 vaccine and 3 booster doses.  Imaging did not reveal pyelonephritis or hydronephrosis.  Patient was treated for urinary tract infection.  She was started on IV Rocephin and tolerated this well..  Patient did not require any therapy for COVID-19 infection.  She remained on room air during her stay.  After couple days, patient white blood cell count had normalized and she was afebrile.  She is medically stable for discharge.
Age: 27.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood glucose normal, Feeling abnormal, Tremor
Clinical narrative: Her arms and hands were slightly shaking, and leg bouncing she reports feeling uneasy.  Patient took 25mg Hydroxyzine (own anxiety rx) and left stable.
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: patient hasnt reported any symptoms but vaccine was given after expiration date., though manufacturer stability and efficacy for the date was warranted
Age: 32.0
Sex: F
Vaccine: FLU4
Symptoms: Chiropractic, Exposure during pregnancy, Massage, Migraine, Nausea
Clinical narrative: Currently 36 weeks pregnant due November 23, 2022. Got the worst migraine of my life starting around 1130pm the night of vaccine which woke me from sleeping and came with neck pain and nausea. Attempted Tylenol, Reglan, sleep, ice, hydration, massage, chiropractor, caffeine, all with minimal relief
Age: 32.0
Sex: F
Vaccine: FLU4
Symptoms: Neck pain, Sleep disorder
Clinical narrative: Currently 36 weeks pregnant due November 23, 2022. Got the worst migraine of my life starting around 1130pm the night of vaccine which woke me from sleeping and came with neck pain and nausea. Attempted Tylenol, Reglan, sleep, ice, hydration, massage, chiropractor, caffeine, all with minimal relief
Age: 73.0
Sex: M
Vaccine: UNK
Symptoms: Pain, Pain in extremity, Rash, Rash erythematous, Rash macular
Clinical narrative: Patient reports pain began in left arm all over 2 days after vaccine. Patient reports pain intensified and is still pretty painful. Patient reports constantly throbbing and reports pain scale of 5 or 6 out of 10. Patient reports rash began 4 days after vaccine and has gotten larger. from shoulder all the way down to his forearm. Rash is splotchy, red and warm to the touch. Pt denies itching. Patient reports rash and pain is still ongoing but not getting worse. Pt currently taking ibuprofen for pain and reports it does help some.
Age: 73.0
Sex: M
Vaccine: UNK
Symptoms: Skin warm
Clinical narrative: Patient reports pain began in left arm all over 2 days after vaccine. Patient reports pain intensified and is still pretty painful. Patient reports constantly throbbing and reports pain scale of 5 or 6 out of 10. Patient reports rash began 4 days after vaccine and has gotten larger. from shoulder all the way down to his forearm. Rash is splotchy, red and warm to the touch. Pt denies itching. Patient reports rash and pain is still ongoing but not getting worse. Pt currently taking ibuprofen for pain and reports it does help some.
Age: 36.0
Sex: F
Vaccine: FLU4, HEP
Symptoms: Pain in extremity
Clinical narrative: Right arm pain since vaccine administration
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient was given Pfizer monovalent instead of Pfizer Bivalent
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chromaturia, Cystitis, Fatigue, Immune-mediated adverse reaction
Clinical narrative: PATIENT EXPERIENCED POLYURIA (EVERY 15 MINUTES) FOR A COUPLE DAYS. URINE WAS DISCOLORED, PER PATIENT IT WAS "BROWNISH AND DARK COLORED". PATIENT WAS EXTREMELY FATIGUED WITH SEVERE BACK AND KIDNEY PAIN. SHE COULD NOT GET OUT OF BED FOR A COUPLE DAYS, THEN IT PROGRESSIVELY GOT BETTER. I SUSPECT AN IMMUNE-MEDIATED CYSTITIS OR KIDNEY INFFLAMATION. I RECOMMENDED THAT THE PATIENT NOT RECEIVE THE SECOND DOSE IN THE SERIES, SINCE SHE IS AN OTHERWISE HEALTHY ADULT WHO HAS RECOVERED FROM COVID TWICE BEFORE RECEIVING THE FIRST DOSE.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Inflammation, Mobility decreased, Polyuria, Renal pain
Clinical narrative: PATIENT EXPERIENCED POLYURIA (EVERY 15 MINUTES) FOR A COUPLE DAYS. URINE WAS DISCOLORED, PER PATIENT IT WAS "BROWNISH AND DARK COLORED". PATIENT WAS EXTREMELY FATIGUED WITH SEVERE BACK AND KIDNEY PAIN. SHE COULD NOT GET OUT OF BED FOR A COUPLE DAYS, THEN IT PROGRESSIVELY GOT BETTER. I SUSPECT AN IMMUNE-MEDIATED CYSTITIS OR KIDNEY INFFLAMATION. I RECOMMENDED THAT THE PATIENT NOT RECEIVE THE SECOND DOSE IN THE SERIES, SINCE SHE IS AN OTHERWISE HEALTHY ADULT WHO HAS RECOVERED FROM COVID TWICE BEFORE RECEIVING THE FIRST DOSE.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Blood albumin decreased, Blood creatine phosphokinase MB increased, Blood creatine phosphokinase normal, Blood creatinine increased
Clinical narrative: Pt presented to the  emergency room due to sore throat over the last 2 days.  She states that feels like her throat on fire and she has difficulty swallowing because of this.  She has complaints of midsternal chest pain with shortness of breath.  She has cough productive at times of yellow sputum.  She denies any fevers or chills, diarrhea/constipation, dysuria.  In the emergency room, she did drop her pulse oximetry as low as 85% when on room air, this improves to 92-94% on 3 L of oxygen via nasal cannula.  She admits to a past history of smoking, is not typically on oxygen at home.  Lab work from the emergency room reveals sodium 139, potassium 3.6, albumin 3.3, glucose 91, BUN 30, creatinine 2.4, HS troponin 160.4, CK 35, CK-MB less than 2.5, magnesium 1.9, WBC 8.01, hemoglobin 10.6.   Patient has a persistent dry cough.  Continues on Decadron and remdesivir, oxygen protocol.  Patient refuses IV fluids for acute renal failure, encouraged to auto hydrate.  Home medications and diet has been resumed.  Requires 2- 3 L of nasal oxygen to maintain satisfactory oxygenation.   Today, 01/05/2022 patient's respiratory status has improved.  She is now oxygenating quite adequately on room air.  She is very insistent on being discharged home today.  Renal function is improving with blood urea nitrogen 35 and creatinine down to 1.6 today.  Serum electrolytes are normal, WBC 12.2, hemoglobin 9.7, platelets 289 K.  CRP is decreased to 10.0 in D-dimer has decreased to 1762. Blood pressure stable and she is afebrile.  On auscultation her lungs are clear, with decreased breath sounds at the right base as before.   We discussed the need to continue quarantine, have follow-up with PCP and of course the patient may return if her symptoms recur or worsen.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Blood electrolytes normal, Blood glucose normal, Blood magnesium normal, Blood potassium normal, Blood sodium normal
Clinical narrative: Pt presented to the  emergency room due to sore throat over the last 2 days.  She states that feels like her throat on fire and she has difficulty swallowing because of this.  She has complaints of midsternal chest pain with shortness of breath.  She has cough productive at times of yellow sputum.  She denies any fevers or chills, diarrhea/constipation, dysuria.  In the emergency room, she did drop her pulse oximetry as low as 85% when on room air, this improves to 92-94% on 3 L of oxygen via nasal cannula.  She admits to a past history of smoking, is not typically on oxygen at home.  Lab work from the emergency room reveals sodium 139, potassium 3.6, albumin 3.3, glucose 91, BUN 30, creatinine 2.4, HS troponin 160.4, CK 35, CK-MB less than 2.5, magnesium 1.9, WBC 8.01, hemoglobin 10.6.   Patient has a persistent dry cough.  Continues on Decadron and remdesivir, oxygen protocol.  Patient refuses IV fluids for acute renal failure, encouraged to auto hydrate.  Home medications and diet has been resumed.  Requires 2- 3 L of nasal oxygen to maintain satisfactory oxygenation.   Today, 01/05/2022 patient's respiratory status has improved.  She is now oxygenating quite adequately on room air.  She is very insistent on being discharged home today.  Renal function is improving with blood urea nitrogen 35 and creatinine down to 1.6 today.  Serum electrolytes are normal, WBC 12.2, hemoglobin 9.7, platelets 289 K.  CRP is decreased to 10.0 in D-dimer has decreased to 1762. Blood pressure stable and she is afebrile.  On auscultation her lungs are clear, with decreased breath sounds at the right base as before.   We discussed the need to continue quarantine, have follow-up with PCP and of course the patient may return if her symptoms recur or worsen.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Blood urea increased, Breath sounds abnormal, C-reactive protein, COVID-19, Chest pain
Clinical narrative: Pt presented to the  emergency room due to sore throat over the last 2 days.  She states that feels like her throat on fire and she has difficulty swallowing because of this.  She has complaints of midsternal chest pain with shortness of breath.  She has cough productive at times of yellow sputum.  She denies any fevers or chills, diarrhea/constipation, dysuria.  In the emergency room, she did drop her pulse oximetry as low as 85% when on room air, this improves to 92-94% on 3 L of oxygen via nasal cannula.  She admits to a past history of smoking, is not typically on oxygen at home.  Lab work from the emergency room reveals sodium 139, potassium 3.6, albumin 3.3, glucose 91, BUN 30, creatinine 2.4, HS troponin 160.4, CK 35, CK-MB less than 2.5, magnesium 1.9, WBC 8.01, hemoglobin 10.6.   Patient has a persistent dry cough.  Continues on Decadron and remdesivir, oxygen protocol.  Patient refuses IV fluids for acute renal failure, encouraged to auto hydrate.  Home medications and diet has been resumed.  Requires 2- 3 L of nasal oxygen to maintain satisfactory oxygenation.   Today, 01/05/2022 patient's respiratory status has improved.  She is now oxygenating quite adequately on room air.  She is very insistent on being discharged home today.  Renal function is improving with blood urea nitrogen 35 and creatinine down to 1.6 today.  Serum electrolytes are normal, WBC 12.2, hemoglobin 9.7, platelets 289 K.  CRP is decreased to 10.0 in D-dimer has decreased to 1762. Blood pressure stable and she is afebrile.  On auscultation her lungs are clear, with decreased breath sounds at the right base as before.   We discussed the need to continue quarantine, have follow-up with PCP and of course the patient may return if her symptoms recur or worsen.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dysphagia, Dyspnoea, Fibrin D dimer, Haemoglobin decreased
Clinical narrative: Pt presented to the  emergency room due to sore throat over the last 2 days.  She states that feels like her throat on fire and she has difficulty swallowing because of this.  She has complaints of midsternal chest pain with shortness of breath.  She has cough productive at times of yellow sputum.  She denies any fevers or chills, diarrhea/constipation, dysuria.  In the emergency room, she did drop her pulse oximetry as low as 85% when on room air, this improves to 92-94% on 3 L of oxygen via nasal cannula.  She admits to a past history of smoking, is not typically on oxygen at home.  Lab work from the emergency room reveals sodium 139, potassium 3.6, albumin 3.3, glucose 91, BUN 30, creatinine 2.4, HS troponin 160.4, CK 35, CK-MB less than 2.5, magnesium 1.9, WBC 8.01, hemoglobin 10.6.   Patient has a persistent dry cough.  Continues on Decadron and remdesivir, oxygen protocol.  Patient refuses IV fluids for acute renal failure, encouraged to auto hydrate.  Home medications and diet has been resumed.  Requires 2- 3 L of nasal oxygen to maintain satisfactory oxygenation.   Today, 01/05/2022 patient's respiratory status has improved.  She is now oxygenating quite adequately on room air.  She is very insistent on being discharged home today.  Renal function is improving with blood urea nitrogen 35 and creatinine down to 1.6 today.  Serum electrolytes are normal, WBC 12.2, hemoglobin 9.7, platelets 289 K.  CRP is decreased to 10.0 in D-dimer has decreased to 1762. Blood pressure stable and she is afebrile.  On auscultation her lungs are clear, with decreased breath sounds at the right base as before.   We discussed the need to continue quarantine, have follow-up with PCP and of course the patient may return if her symptoms recur or worsen.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Platelet count normal, Productive cough, Renal impairment, SARS-CoV-2 test positive
Clinical narrative: Pt presented to the  emergency room due to sore throat over the last 2 days.  She states that feels like her throat on fire and she has difficulty swallowing because of this.  She has complaints of midsternal chest pain with shortness of breath.  She has cough productive at times of yellow sputum.  She denies any fevers or chills, diarrhea/constipation, dysuria.  In the emergency room, she did drop her pulse oximetry as low as 85% when on room air, this improves to 92-94% on 3 L of oxygen via nasal cannula.  She admits to a past history of smoking, is not typically on oxygen at home.  Lab work from the emergency room reveals sodium 139, potassium 3.6, albumin 3.3, glucose 91, BUN 30, creatinine 2.4, HS troponin 160.4, CK 35, CK-MB less than 2.5, magnesium 1.9, WBC 8.01, hemoglobin 10.6.   Patient has a persistent dry cough.  Continues on Decadron and remdesivir, oxygen protocol.  Patient refuses IV fluids for acute renal failure, encouraged to auto hydrate.  Home medications and diet has been resumed.  Requires 2- 3 L of nasal oxygen to maintain satisfactory oxygenation.   Today, 01/05/2022 patient's respiratory status has improved.  She is now oxygenating quite adequately on room air.  She is very insistent on being discharged home today.  Renal function is improving with blood urea nitrogen 35 and creatinine down to 1.6 today.  Serum electrolytes are normal, WBC 12.2, hemoglobin 9.7, platelets 289 K.  CRP is decreased to 10.0 in D-dimer has decreased to 1762. Blood pressure stable and she is afebrile.  On auscultation her lungs are clear, with decreased breath sounds at the right base as before.   We discussed the need to continue quarantine, have follow-up with PCP and of course the patient may return if her symptoms recur or worsen.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Sputum discoloured, Throat irritation, Troponin increased, White blood cell count increased
Clinical narrative: Pt presented to the  emergency room due to sore throat over the last 2 days.  She states that feels like her throat on fire and she has difficulty swallowing because of this.  She has complaints of midsternal chest pain with shortness of breath.  She has cough productive at times of yellow sputum.  She denies any fevers or chills, diarrhea/constipation, dysuria.  In the emergency room, she did drop her pulse oximetry as low as 85% when on room air, this improves to 92-94% on 3 L of oxygen via nasal cannula.  She admits to a past history of smoking, is not typically on oxygen at home.  Lab work from the emergency room reveals sodium 139, potassium 3.6, albumin 3.3, glucose 91, BUN 30, creatinine 2.4, HS troponin 160.4, CK 35, CK-MB less than 2.5, magnesium 1.9, WBC 8.01, hemoglobin 10.6.   Patient has a persistent dry cough.  Continues on Decadron and remdesivir, oxygen protocol.  Patient refuses IV fluids for acute renal failure, encouraged to auto hydrate.  Home medications and diet has been resumed.  Requires 2- 3 L of nasal oxygen to maintain satisfactory oxygenation.   Today, 01/05/2022 patient's respiratory status has improved.  She is now oxygenating quite adequately on room air.  She is very insistent on being discharged home today.  Renal function is improving with blood urea nitrogen 35 and creatinine down to 1.6 today.  Serum electrolytes are normal, WBC 12.2, hemoglobin 9.7, platelets 289 K.  CRP is decreased to 10.0 in D-dimer has decreased to 1762. Blood pressure stable and she is afebrile.  On auscultation her lungs are clear, with decreased breath sounds at the right base as before.   We discussed the need to continue quarantine, have follow-up with PCP and of course the patient may return if her symptoms recur or worsen.
Age: 83.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Chest discomfort, Dizziness, Dyspnoea
Clinical narrative: Client felt faint felt some tightness in chest, shortness of breath--reported that the sx resolved w/n 30 minutes but will have an appointment with her provider
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Guillain-Barre syndrome, Walking aid user
Clinical narrative: Patient's wife states that patient developed Guillain-Barré syndrome shortly following administration of MRNA COVID 19 vaccine in March 2020. She states that since this incident the patient has required the use of a walker device.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chest discomfort, Chills, Cough, Fatigue, Headache
Clinical narrative: Heart rate and b/p extremely high, chills, chest tightness, headache, blurred vision, muscle weakness and dry cough and fatigue. It's been a week still has fatigue. Second booster. 4th shot.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Heart rate increased, Hypertension, Muscular weakness, Vision blurred
Clinical narrative: Heart rate and b/p extremely high, chills, chest tightness, headache, blurred vision, muscle weakness and dry cough and fatigue. It's been a week still has fatigue. Second booster. 4th shot.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Client presented to vaccine clinic for 1st dose of Moderna (monovalent-primary series). Moderna bivalent given instead of Moderna monovalent. Per CDC, dose repeated with Moderna monovalent.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Rhinorrhoea, SARS-CoV-2 test
Clinical narrative: I had sniffles and fatigue.
Age: 43.0
Sex: F
Vaccine: COVID19-2
Symptoms: Anaphylactic reaction, Dyspnoea, Injection site erythema, Injection site swelling, Pallor
Clinical narrative: Anaphylactic type reaction requiring Epipen. Shortness of breath, closure of airways, vomiting, pale face, redness and swelling at injection site
Age: 43.0
Sex: F
Vaccine: COVID19-2
Symptoms: Throat tightness, Vomiting
Clinical narrative: Anaphylactic type reaction requiring Epipen. Shortness of breath, closure of airways, vomiting, pale face, redness and swelling at injection site
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pain, Headache, Pain, Pain in extremity, Pyrexia
Clinical narrative: Case had arm pain the night of the vaccination. Case woke up the next morning with eye pain, blurry vision, headache, bodyaches and a fever of 103.2. Case states that this also happened with first dose. Case did call personal physician.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: Case had arm pain the night of the vaccination. Case woke up the next morning with eye pain, blurry vision, headache, bodyaches and a fever of 103.2. Case states that this also happened with first dose. Case did call personal physician.
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Asthenia, COVID-19, Cough, Disturbance in attention, Fatigue
Clinical narrative: The first symptoms were coughing, sneezing, congestion. There was weakness, fatigue, and insomnia. I started on the PAXLOVID, so I can't tell you if this is because of the medication or the virus, but I had hallucinatory imagery when I closed my eyes. I think I had a neurological response because I had an episode of rigidity in my right hand. I could not bend my fingers. I have had a sense of fogginess. its better now but I am since experiencing it. I also have lack of concentration.
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Feeling abnormal, Hallucination, Insomnia, Muscle rigidity, Musculoskeletal stiffness
Clinical narrative: The first symptoms were coughing, sneezing, congestion. There was weakness, fatigue, and insomnia. I started on the PAXLOVID, so I can't tell you if this is because of the medication or the virus, but I had hallucinatory imagery when I closed my eyes. I think I had a neurological response because I had an episode of rigidity in my right hand. I could not bend my fingers. I have had a sense of fogginess. its better now but I am since experiencing it. I also have lack of concentration.
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Nervous system disorder, Respiratory tract congestion, SARS-CoV-2 test positive, Sneezing
Clinical narrative: The first symptoms were coughing, sneezing, congestion. There was weakness, fatigue, and insomnia. I started on the PAXLOVID, so I can't tell you if this is because of the medication or the virus, but I had hallucinatory imagery when I closed my eyes. I think I had a neurological response because I had an episode of rigidity in my right hand. I could not bend my fingers. I have had a sense of fogginess. its better now but I am since experiencing it. I also have lack of concentration.
Age: 33.0
Sex: M
Vaccine: FLUC4
Symptoms: Injection site erythema, Injection site pruritus, Pruritus
Clinical narrative: Had redness and itching to the injection site within 5 minutes. About 10 minutes after the injection complained of itching all over body.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Movement disorder, Periarthritis
Clinical narrative: FROZEN SHOULDER Currently unable to move In physical Therapy. My wife has been in PT for four months post her frozen shoulder I will report hers next.
Age: 75.0
Sex: F
Vaccine: COVID19-2, UNK
Symptoms: COVID-19, Cough, Dyspnoea, Nasal congestion, Quarantine
Clinical narrative: It started with sniffles which progressed to a very stuffy nose, a scratchy throat, and a hacking cough. On the 3rd day, I saw a doctor. I tested positive for COVID-19. He prescribed cough medicine. He told me to go to the hospital if I had trouble breathing, but that never happened. I quarantined for 5 days. By the 10th day, I felt fine and traveled back home.
Age: 75.0
Sex: F
Vaccine: COVID19-2, UNK
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive, Throat irritation
Clinical narrative: It started with sniffles which progressed to a very stuffy nose, a scratchy throat, and a hacking cough. On the 3rd day, I saw a doctor. I tested positive for COVID-19. He prescribed cough medicine. He told me to go to the hospital if I had trouble breathing, but that never happened. I quarantined for 5 days. By the 10th day, I felt fine and traveled back home.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asymptomatic COVID-19, Cerebrovascular accident, SARS-CoV-2 test positive
Clinical narrative: Pt was admitted on 10/19 for CVA. She was due to be transferred to 3W for inpatient rehab and required a COVID test which was positive on 10/25. She is asymptomatic at this time.
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: Demyelination, Injection site muscle weakness, Neuralgic amyotrophy
Clinical narrative: I had a demyelinating event of my left brachial plexus It is known as Parsonage-Turner syndrome.  I have lost the use of my left shoulder muscles at this time.
Age: 29.0
Sex: F
Vaccine: UNK, UNK
Symptoms: Headache
Clinical narrative: had a headache with each vaccine, and now constantly getting more frequent headaches every other day
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The booster dose of Pediatric Pfizer (5-11 years) was given to patient on 10/03/2022. The information that we perceived at the time was: expiration date 10/31/2022 (based on manufactured date 10/2021), and beyond use date was 10 weeks from fridge date (fridge date was 08/22/2022, BUD is 10/31/2022). The information to recall was received on 10/12/2022 and the product was isolated on the date of.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Blood culture negative, Blood lactic acid normal, Brain natriuretic peptide increased, Bronchial secretion retention
Clinical narrative: COVID+ 10/13/22  -Vaccination status - pfizer x3   DATE OF ADMISSION:  10/13/2022 DATE OF DISCHARGE:    HOSPITAL COURSE The patient is a very pleasant 67-year-old female with past medical history as listed above including multiple myeloma, who presented to hospital as a transfer from outlying facility secondary to shortness of breath and worsening dyspnea on exertion.  Initial laboratory studies and imaging can be found per review.  The patient was hypoxic with O2 saturation of 87% on room air in the ED.  She was COVID positive.  Blood cultures were obtained and were negative.  Lactate was normal.  BNP 1674 and normal troponins.  CTA of the chest was negative for PE but showed bilateral lower lobe pneumonia with multifocal bilateral lower lobe mucous plugging.  She was transferred to hospital under the Oncology Service and started on remdesivir.  She was placed on dexamethasone for hypoxia.  She was started on antibiotics for superimposed bacterial pneumonia.  Pulmonology was consulted.  MRSA was negative.  Broad-spectrum antibiotics were initially recommended.  Streptococcus and Legionella were negative.  MRSA screen was negative.  Infectious Disease was consulted, who agreed with remdesivir and okay to stop at discharge.  They also agree with dexamethasone.  Recommended continuing or finish a 5-day course of ceftriaxone, azithromycin or stop at discharge.  The patient was hypotensive in the ED with a blood pressure of 74/57.  This improved with fluid bolus.  Her atenolol was held, then resumed with stable blood pressures.  She had transaminitis that is improving.  We will continue to hold her Lipitor.  Overall, she did well during the course of the hospital stay.  Her oxygen was weaned off and she was felt medically stable for discharge on 10/17/2022 in stable condition.  MEDICATIONS AT DISCHARGE Atenolol 50 mg per PEG daily, Wellbutrin XL 300 mg daily, Mucinex 600 mg b.i.d., levofloxacin 750 mg for 2 days, levothyroxine 88 mcg daily, Osmolite tube feeds as before, albuterol 2 puffs q.6 hours p.r.n., BMX solution 10 mL every 3 hours p.r.n., Zyrtec 10 mg daily p.r.n., Pepcid 20 mg b.i.d. p.r.n., DuoNeb 3 mL nebulizer every 6 hours p.r.n., Trelegy Ellipta 1 inhalation daily.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Dyspnoea exertional, Hypertransaminasaemia, Hypoxia
Clinical narrative: COVID+ 10/13/22  -Vaccination status - pfizer x3   DATE OF ADMISSION:  10/13/2022 DATE OF DISCHARGE:    HOSPITAL COURSE The patient is a very pleasant 67-year-old female with past medical history as listed above including multiple myeloma, who presented to hospital as a transfer from outlying facility secondary to shortness of breath and worsening dyspnea on exertion.  Initial laboratory studies and imaging can be found per review.  The patient was hypoxic with O2 saturation of 87% on room air in the ED.  She was COVID positive.  Blood cultures were obtained and were negative.  Lactate was normal.  BNP 1674 and normal troponins.  CTA of the chest was negative for PE but showed bilateral lower lobe pneumonia with multifocal bilateral lower lobe mucous plugging.  She was transferred to hospital under the Oncology Service and started on remdesivir.  She was placed on dexamethasone for hypoxia.  She was started on antibiotics for superimposed bacterial pneumonia.  Pulmonology was consulted.  MRSA was negative.  Broad-spectrum antibiotics were initially recommended.  Streptococcus and Legionella were negative.  MRSA screen was negative.  Infectious Disease was consulted, who agreed with remdesivir and okay to stop at discharge.  They also agree with dexamethasone.  Recommended continuing or finish a 5-day course of ceftriaxone, azithromycin or stop at discharge.  The patient was hypotensive in the ED with a blood pressure of 74/57.  This improved with fluid bolus.  Her atenolol was held, then resumed with stable blood pressures.  She had transaminitis that is improving.  We will continue to hold her Lipitor.  Overall, she did well during the course of the hospital stay.  Her oxygen was weaned off and she was felt medically stable for discharge on 10/17/2022 in stable condition.  MEDICATIONS AT DISCHARGE Atenolol 50 mg per PEG daily, Wellbutrin XL 300 mg daily, Mucinex 600 mg b.i.d., levofloxacin 750 mg for 2 days, levothyroxine 88 mcg daily, Osmolite tube feeds as before, albuterol 2 puffs q.6 hours p.r.n., BMX solution 10 mL every 3 hours p.r.n., Zyrtec 10 mg daily p.r.n., Pepcid 20 mg b.i.d. p.r.n., DuoNeb 3 mL nebulizer every 6 hours p.r.n., Trelegy Ellipta 1 inhalation daily.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Imaging procedure, Laboratory test, Legionella test, Pneumonia, Pneumonia bacterial
Clinical narrative: COVID+ 10/13/22  -Vaccination status - pfizer x3   DATE OF ADMISSION:  10/13/2022 DATE OF DISCHARGE:    HOSPITAL COURSE The patient is a very pleasant 67-year-old female with past medical history as listed above including multiple myeloma, who presented to hospital as a transfer from outlying facility secondary to shortness of breath and worsening dyspnea on exertion.  Initial laboratory studies and imaging can be found per review.  The patient was hypoxic with O2 saturation of 87% on room air in the ED.  She was COVID positive.  Blood cultures were obtained and were negative.  Lactate was normal.  BNP 1674 and normal troponins.  CTA of the chest was negative for PE but showed bilateral lower lobe pneumonia with multifocal bilateral lower lobe mucous plugging.  She was transferred to hospital under the Oncology Service and started on remdesivir.  She was placed on dexamethasone for hypoxia.  She was started on antibiotics for superimposed bacterial pneumonia.  Pulmonology was consulted.  MRSA was negative.  Broad-spectrum antibiotics were initially recommended.  Streptococcus and Legionella were negative.  MRSA screen was negative.  Infectious Disease was consulted, who agreed with remdesivir and okay to stop at discharge.  They also agree with dexamethasone.  Recommended continuing or finish a 5-day course of ceftriaxone, azithromycin or stop at discharge.  The patient was hypotensive in the ED with a blood pressure of 74/57.  This improved with fluid bolus.  Her atenolol was held, then resumed with stable blood pressures.  She had transaminitis that is improving.  We will continue to hold her Lipitor.  Overall, she did well during the course of the hospital stay.  Her oxygen was weaned off and she was felt medically stable for discharge on 10/17/2022 in stable condition.  MEDICATIONS AT DISCHARGE Atenolol 50 mg per PEG daily, Wellbutrin XL 300 mg daily, Mucinex 600 mg b.i.d., levofloxacin 750 mg for 2 days, levothyroxine 88 mcg daily, Osmolite tube feeds as before, albuterol 2 puffs q.6 hours p.r.n., BMX solution 10 mL every 3 hours p.r.n., Zyrtec 10 mg daily p.r.n., Pepcid 20 mg b.i.d. p.r.n., DuoNeb 3 mL nebulizer every 6 hours p.r.n., Trelegy Ellipta 1 inhalation daily.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Staphylococcus test negative, Streptococcus test negative, Superinfection, Troponin normal
Clinical narrative: COVID+ 10/13/22  -Vaccination status - pfizer x3   DATE OF ADMISSION:  10/13/2022 DATE OF DISCHARGE:    HOSPITAL COURSE The patient is a very pleasant 67-year-old female with past medical history as listed above including multiple myeloma, who presented to hospital as a transfer from outlying facility secondary to shortness of breath and worsening dyspnea on exertion.  Initial laboratory studies and imaging can be found per review.  The patient was hypoxic with O2 saturation of 87% on room air in the ED.  She was COVID positive.  Blood cultures were obtained and were negative.  Lactate was normal.  BNP 1674 and normal troponins.  CTA of the chest was negative for PE but showed bilateral lower lobe pneumonia with multifocal bilateral lower lobe mucous plugging.  She was transferred to hospital under the Oncology Service and started on remdesivir.  She was placed on dexamethasone for hypoxia.  She was started on antibiotics for superimposed bacterial pneumonia.  Pulmonology was consulted.  MRSA was negative.  Broad-spectrum antibiotics were initially recommended.  Streptococcus and Legionella were negative.  MRSA screen was negative.  Infectious Disease was consulted, who agreed with remdesivir and okay to stop at discharge.  They also agree with dexamethasone.  Recommended continuing or finish a 5-day course of ceftriaxone, azithromycin or stop at discharge.  The patient was hypotensive in the ED with a blood pressure of 74/57.  This improved with fluid bolus.  Her atenolol was held, then resumed with stable blood pressures.  She had transaminitis that is improving.  We will continue to hold her Lipitor.  Overall, she did well during the course of the hospital stay.  Her oxygen was weaned off and she was felt medically stable for discharge on 10/17/2022 in stable condition.  MEDICATIONS AT DISCHARGE Atenolol 50 mg per PEG daily, Wellbutrin XL 300 mg daily, Mucinex 600 mg b.i.d., levofloxacin 750 mg for 2 days, levothyroxine 88 mcg daily, Osmolite tube feeds as before, albuterol 2 puffs q.6 hours p.r.n., BMX solution 10 mL every 3 hours p.r.n., Zyrtec 10 mg daily p.r.n., Pepcid 20 mg b.i.d. p.r.n., DuoNeb 3 mL nebulizer every 6 hours p.r.n., Trelegy Ellipta 1 inhalation daily.
Age: 66.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Cough, Dyspnoea, Productive cough, Rhinorrhoea, Secretion discharge
Clinical narrative: On around 10/12/2022, I began having a runny nose. I don't think I have ever had a runny nose that bad in my life. A few days later, I developed a minor cough. Sunday, my cough had progressed, and I was coughing up a large amount of thick, yellow, mucus. The following Monday, I called my doctor who prescribed Prednisone and Ciprofloxacin. Today, I am not coughing up the mucus anymore and I am breathing much better again.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Injected limb mobility decreased, Pain, Periarthritis
Clinical narrative: Frozen shoulder extreme unbearable pain four months into physical therapy and left arm still unusable
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Asthenia, Atelectasis, Blood creatinine increased, C-reactive protein increased
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 10/12/2022 Discharge Date: Oct 19, 2022  HOSPITAL COURSE: Patient is an 86-year-old man with complex medical history who presented to our institution with weakness, falls and confusion.  He was recently diagnosed with COVID-19 on 10/08/2022.  His family is having an increasingly difficult time caring for him.  He was found on the ground after sliding off the chair.  He is noted to have decreased appetite as well as diarrhea and shortness of breath.  As an outpatient he was treated with molnupiravir however continue to worsen.   Upon arrival to emergency department, he was identified to have fever and leukocytosis, chest x-ray showed some pulmonary vascular congestion with bibasilar atelectasis.  He is felt to have sepsis syndrome, and this was felt to be predominantly related to COVID-19.  Is also found to have acute kidney injury with creatinine of 1.99.  As well as concern for acute on chronic systolic congestive Heart failure, he received 40 mg of IV Lasix in the emergency department and is admitted to the internal medicine service for further workup and management.   Patient initially showed no hypoxemia, however developed hypoxemia during hospitalization, at which time is initiated on dexamethasone and remdesivir.  He is found have a significant elevation of CRP at 300. He underwent CT imaging with findings of multifocal pneumonia consistent with COVID-19.  He had a rising white blood cell count with elevated procalcitonin, as well as a high risk for aspiration, therefore he was empirically started on Rocephin and doxycycline to complete a 5 day course.  Patient's respiratory status began to improve, and oxygen was weaned.  At discharge patient was maintaining normal O2 sats on room air.   He will complete total of 10 days of dexamethasone therapy.   In regards to the patient's toxic metabolic encephalopathy which was present on admission secondary to COVID-19 pneumonia, this resolved, patient is back to his mental status baseline.   Patient was weak from his recent infection, he was seen by PT and OT and subacute rehabilitation was recommended.   Patient has acute kidney injury resolved.  Discharge creatinine 1.8, which was consistent with his previous baseline creatinine.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Computerised tomogram thorax abnormal, Confusional state
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 10/12/2022 Discharge Date: Oct 19, 2022  HOSPITAL COURSE: Patient is an 86-year-old man with complex medical history who presented to our institution with weakness, falls and confusion.  He was recently diagnosed with COVID-19 on 10/08/2022.  His family is having an increasingly difficult time caring for him.  He was found on the ground after sliding off the chair.  He is noted to have decreased appetite as well as diarrhea and shortness of breath.  As an outpatient he was treated with molnupiravir however continue to worsen.   Upon arrival to emergency department, he was identified to have fever and leukocytosis, chest x-ray showed some pulmonary vascular congestion with bibasilar atelectasis.  He is felt to have sepsis syndrome, and this was felt to be predominantly related to COVID-19.  Is also found to have acute kidney injury with creatinine of 1.99.  As well as concern for acute on chronic systolic congestive Heart failure, he received 40 mg of IV Lasix in the emergency department and is admitted to the internal medicine service for further workup and management.   Patient initially showed no hypoxemia, however developed hypoxemia during hospitalization, at which time is initiated on dexamethasone and remdesivir.  He is found have a significant elevation of CRP at 300. He underwent CT imaging with findings of multifocal pneumonia consistent with COVID-19.  He had a rising white blood cell count with elevated procalcitonin, as well as a high risk for aspiration, therefore he was empirically started on Rocephin and doxycycline to complete a 5 day course.  Patient's respiratory status began to improve, and oxygen was weaned.  At discharge patient was maintaining normal O2 sats on room air.   He will complete total of 10 days of dexamethasone therapy.   In regards to the patient's toxic metabolic encephalopathy which was present on admission secondary to COVID-19 pneumonia, this resolved, patient is back to his mental status baseline.   Patient was weak from his recent infection, he was seen by PT and OT and subacute rehabilitation was recommended.   Patient has acute kidney injury resolved.  Discharge creatinine 1.8, which was consistent with his previous baseline creatinine.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Diarrhoea, Dyspnoea, Fall, Hypoxia
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 10/12/2022 Discharge Date: Oct 19, 2022  HOSPITAL COURSE: Patient is an 86-year-old man with complex medical history who presented to our institution with weakness, falls and confusion.  He was recently diagnosed with COVID-19 on 10/08/2022.  His family is having an increasingly difficult time caring for him.  He was found on the ground after sliding off the chair.  He is noted to have decreased appetite as well as diarrhea and shortness of breath.  As an outpatient he was treated with molnupiravir however continue to worsen.   Upon arrival to emergency department, he was identified to have fever and leukocytosis, chest x-ray showed some pulmonary vascular congestion with bibasilar atelectasis.  He is felt to have sepsis syndrome, and this was felt to be predominantly related to COVID-19.  Is also found to have acute kidney injury with creatinine of 1.99.  As well as concern for acute on chronic systolic congestive Heart failure, he received 40 mg of IV Lasix in the emergency department and is admitted to the internal medicine service for further workup and management.   Patient initially showed no hypoxemia, however developed hypoxemia during hospitalization, at which time is initiated on dexamethasone and remdesivir.  He is found have a significant elevation of CRP at 300. He underwent CT imaging with findings of multifocal pneumonia consistent with COVID-19.  He had a rising white blood cell count with elevated procalcitonin, as well as a high risk for aspiration, therefore he was empirically started on Rocephin and doxycycline to complete a 5 day course.  Patient's respiratory status began to improve, and oxygen was weaned.  At discharge patient was maintaining normal O2 sats on room air.   He will complete total of 10 days of dexamethasone therapy.   In regards to the patient's toxic metabolic encephalopathy which was present on admission secondary to COVID-19 pneumonia, this resolved, patient is back to his mental status baseline.   Patient was weak from his recent infection, he was seen by PT and OT and subacute rehabilitation was recommended.   Patient has acute kidney injury resolved.  Discharge creatinine 1.8, which was consistent with his previous baseline creatinine.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Leukocytosis, Metabolic encephalopathy, Procalcitonin increased, Pulmonary congestion, Pyrexia
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 10/12/2022 Discharge Date: Oct 19, 2022  HOSPITAL COURSE: Patient is an 86-year-old man with complex medical history who presented to our institution with weakness, falls and confusion.  He was recently diagnosed with COVID-19 on 10/08/2022.  His family is having an increasingly difficult time caring for him.  He was found on the ground after sliding off the chair.  He is noted to have decreased appetite as well as diarrhea and shortness of breath.  As an outpatient he was treated with molnupiravir however continue to worsen.   Upon arrival to emergency department, he was identified to have fever and leukocytosis, chest x-ray showed some pulmonary vascular congestion with bibasilar atelectasis.  He is felt to have sepsis syndrome, and this was felt to be predominantly related to COVID-19.  Is also found to have acute kidney injury with creatinine of 1.99.  As well as concern for acute on chronic systolic congestive Heart failure, he received 40 mg of IV Lasix in the emergency department and is admitted to the internal medicine service for further workup and management.   Patient initially showed no hypoxemia, however developed hypoxemia during hospitalization, at which time is initiated on dexamethasone and remdesivir.  He is found have a significant elevation of CRP at 300. He underwent CT imaging with findings of multifocal pneumonia consistent with COVID-19.  He had a rising white blood cell count with elevated procalcitonin, as well as a high risk for aspiration, therefore he was empirically started on Rocephin and doxycycline to complete a 5 day course.  Patient's respiratory status began to improve, and oxygen was weaned.  At discharge patient was maintaining normal O2 sats on room air.   He will complete total of 10 days of dexamethasone therapy.   In regards to the patient's toxic metabolic encephalopathy which was present on admission secondary to COVID-19 pneumonia, this resolved, patient is back to his mental status baseline.   Patient was weak from his recent infection, he was seen by PT and OT and subacute rehabilitation was recommended.   Patient has acute kidney injury resolved.  Discharge creatinine 1.8, which was consistent with his previous baseline creatinine.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Sepsis, White blood cell count increased
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 10/12/2022 Discharge Date: Oct 19, 2022  HOSPITAL COURSE: Patient is an 86-year-old man with complex medical history who presented to our institution with weakness, falls and confusion.  He was recently diagnosed with COVID-19 on 10/08/2022.  His family is having an increasingly difficult time caring for him.  He was found on the ground after sliding off the chair.  He is noted to have decreased appetite as well as diarrhea and shortness of breath.  As an outpatient he was treated with molnupiravir however continue to worsen.   Upon arrival to emergency department, he was identified to have fever and leukocytosis, chest x-ray showed some pulmonary vascular congestion with bibasilar atelectasis.  He is felt to have sepsis syndrome, and this was felt to be predominantly related to COVID-19.  Is also found to have acute kidney injury with creatinine of 1.99.  As well as concern for acute on chronic systolic congestive Heart failure, he received 40 mg of IV Lasix in the emergency department and is admitted to the internal medicine service for further workup and management.   Patient initially showed no hypoxemia, however developed hypoxemia during hospitalization, at which time is initiated on dexamethasone and remdesivir.  He is found have a significant elevation of CRP at 300. He underwent CT imaging with findings of multifocal pneumonia consistent with COVID-19.  He had a rising white blood cell count with elevated procalcitonin, as well as a high risk for aspiration, therefore he was empirically started on Rocephin and doxycycline to complete a 5 day course.  Patient's respiratory status began to improve, and oxygen was weaned.  At discharge patient was maintaining normal O2 sats on room air.   He will complete total of 10 days of dexamethasone therapy.   In regards to the patient's toxic metabolic encephalopathy which was present on admission secondary to COVID-19 pneumonia, this resolved, patient is back to his mental status baseline.   Patient was weak from his recent infection, he was seen by PT and OT and subacute rehabilitation was recommended.   Patient has acute kidney injury resolved.  Discharge creatinine 1.8, which was consistent with his previous baseline creatinine.
Age: 43.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, Fatigue, Laboratory test normal, Nervousness, Pain
Clinical narrative: Later, that night around 6 I had the typical reaction very fatigue and joint pain and a low-grade fever of 100. Then I started having pain in the growing area and with the past shots it would normally be in the shoulders making difficult to even turn my neck. Here we are two weeks later, and I am still in so much pain that it is making me nervous. I called my Primary last week, and they did a UTI test and they also tried to test for blood cancer, but I declined that test. I go back for a follow up in a few weeks.
Age: 43.0
Sex: F
Vaccine: COVID19-2
Symptoms: Urine analysis normal
Clinical narrative: Later, that night around 6 I had the typical reaction very fatigue and joint pain and a low-grade fever of 100. Then I started having pain in the growing area and with the past shots it would normally be in the shoulders making difficult to even turn my neck. Here we are two weeks later, and I am still in so much pain that it is making me nervous. I called my Primary last week, and they did a UTI test and they also tried to test for blood cancer, but I declined that test. I go back for a follow up in a few weeks.
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Malaise, Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I had my vaccination on 09/26/2022. On 10/08/2022 started to feel unwell with sore throat. Then on 10/09/2022 I tested COVID-19 positive. I contacted my doctor on 10/09/2022 and was prescribed PAXLOVID. I have slight amount of residual congestion on 10/26/2022.